Unlike traditional drugs ... new data, changes in the manufacturing process, or updated regulatory requirements. The increasing complexity of emerging therapies and the need for faster development ...

Between 2007 and 2016, 77% of Food and Drug Administration-approved new drugs were small molecule treatments, which typically come in the form of pills or tablets.

Unfortunately, a federal policy implemented as part of the Inflation Reduction Act (IRA) could have a disastrous impact on new medication development, harming our local innovation ... investment in a ...

This design process is known ... development, increasing yields, reducing waste, and enhancing efficiency. As a result, new drugs are brought to market more quickly than in previous decades ...

Fox News' Health newsletter brings you stories on the latest developments in health care, wellness, diseases, mental health and more.

In this transformative environment, a new drug development paradigm is needed if healthcare is to remain both effective and affordable. The future of drug development and the central role that ...

It can take several weeks to bounce back after a bout of COVID-19, but some people develop more persistent problems. The ...

Digital Insurance reached out to insurance professionals for comments related to new and emerging insurance risks to watch in 2025. Technology and climate change are highlighted by the respondents as ...

The decision greenlights a new biomarker endpoint, minimal residual disease, for accelerated drug approval in multiple myeloma, and researchers say it could cut a decade off the drug development ...

Furthermore, the drug was 89% effective at preventing all types of doctor visits for RSV, which is short for "respiratory syncytial virus." The new research, published Monday (Dec. 9) in the ...

These include its catalytic reduction to nitrite and its isomerization to nitrate by metalloporphyrins, which have led to potential candidates for drug development for cardiovascular, inflammatory ...

The 8th Meeting of the BIMSTEC Sub-Group on Prevention of Illicit Trafficking in Narcotic Drugs, Psychotropic Substances, and ...